Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134368
Status:
COMPLETED
Last Update Posted:
2008-08-07
First Post:
2005-08-22
Brief Title:
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Study Overview
Official Title:
Pilot Investigator-Initiated Proof-of-Concept Study of the Efficacy and Safety of Etanercept Enbrel in Adults With Vitiligo
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the efficacy and safety of etanercept in adults with vitiligo
Detailed Description:
Subjects will self-administer etanercept 50 mg SQ twice weekly for 6 months Lesion repigmentation will be evaluated at monthly visits
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None